NF-κB is known to be activated in the synovium of patients with RA to regulate the genes contributing to inflammation, such as TNF, IL-6, and IL-8, and treatment therapy targeting this gene is under study [5]. This evidence concerns the gene NFKB1 and rheumatoid arthritis.